Immune-related pancreatitis secondary to nivolumab in a patient with recurrent lung adenocarcinoma: A case report

被引：43

作者：

Ikeuchi, Kazuhiko ^{[1
]}

Okuma, Yusuke ^{[1
]}

Tabata, Taku ^{[2
]}

机构：

[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Bunkyo Ku, Honkomagome 3-18-22, Tokyo 1138677, Japan

[2] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Gastroenterol, Bunkyo Ku, Honkomagome 3-18-22, Tokyo 1138677, Japan

来源：

LUNG CANCER | 2016年 / 99卷

关键词：

Immune-related pancreatitis; Nivolumab; Lung adenocarcinoma; Immune-checkpoint inhibitor; MANAGEMENT; TOXICITIES; DOCETAXEL; ANTIBODY; THERAPY; CANCER;

D O I：

10.1016/j.lungcan.2016.07.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immune checkpoint inhibitor is a verified standard of care as a second-line chemotherapy for non-small cell lung cancer. Management of immune-related adverse effects (irAEs) is crucial for ensuring patient safety. However, less frequent irAEs may result in complications. Here, we report a patient with recurrent lung adenocarcinoma who was treated with nivolumab and developed immune-related pancreatitis. A 66-year-old Japanese female with recurrent lung adenocarcinoma and metastatic lymph nodes presented with anorexia, vomiting, and back pain on day 18 of two cycles of nivolumab. Laboratory data demonstrated a grade 3 elevation of serum amylase and lipase levels. Initially, no abnormality could be detected on computed tomography (CT), magnetic resonance cholangiopancreatography (MRCP), or the Gallium scan. The patient was treated with high-dose prednisone, resulting in gradual improvement of symptoms and laboratory data. A follow-up MRCP revealed a swollen pancreas and pancreatic inflammation. Immune-related pancreatitis is a rare type of nivolumab-induced irAE that shows no significant changes on radiologic imaging, except for a swollen pancreas on CT, and can be suppressed using high-dose prednisone. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

引用

页码：148 / 150

页数：3

共 13 条

[1] Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT [J].

Alabed, Yazan Z. ;

Aghayev, Ayaz ;

Sakellis, Christopher ;

Van den Abbeele, Annick D. .

CLINICAL NUCLEAR MEDICINE, 2015, 40 (11) :e528-e529

[2] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[3] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[4] Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper [J].

Champiat, S. ;

Lambotte, O. ;

Barreau, E. ;

Belkhir, R. ;

Berdelou, A. ;

Carbonnel, F. ;

Cauquil, C. ;

Chanson, P. ;

Collins, M. ;

Durrbach, A. ;

Ederhy, S. ;

Feuillet, S. ;

Francois, H. ;

Lazarovici, J. ;

Le Pavec, J. ;

De Martin, E. ;

Mateus, C. ;

Michot, J. -M. ;

Samuel, D. ;

Soria, J. -C. ;

Robert, C. ;

Eggermont, A. ;

Marabelle, A. .

ANNALS OF ONCOLOGY, 2016, 27 (04) :559-574

[5] Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases [J].

Di Giacomo, Anna Maria ;

Danielli, Riccardo ;

Guidoboni, Massimo ;

Calabro, Luana ;

Carlucci, Dora ;

Miracco, Clelia ;

Volterrani, Luca ;

Mazzei, Maria Antonietta ;

Biagioli, Maurizio ;

Altomonte, Maresa ;

Maio, Michele .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (08) :1297-1306

[6] Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy [J].

Eigentler, Thomas K. ;

Hassel, Jessica C. ;

Berking, Carola ;

Aberle, Jens ;

Bachmann, Oliver ;

Gruenwald, Viktor ;

Kaehler, Katharina C. ;

Loquai, Carmen ;

Reinmuth, Niels ;

Steins, Martin ;

Zimmer, Lisa ;

Sendl, Anna ;

Gutzmer, Ralf .

CANCER TREATMENT REVIEWS, 2016, 45 :7-18

[7] Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes [J].

Freeman-Keller, Morganna ;

Kim, Youngchul ;

Cronin, Heather ;

Richards, Allison ;

Gibney, Geoffrey ;

Weber, Jeffrey S. .

CLINICAL CANCER RESEARCH, 2016, 22 (04) :886-894

[8] Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy [J].

Hofmann, Lars ;

Forschner, Andrea ;

Loquai, Carmen ;

Goldinger, Simone M. ;

Zimmer, Lisa ;

Ugurel, Selma ;

Schmidgen, Maria I. ;

Gutzmer, Ralf ;

Utikal, Jochen S. ;

Goeppner, Daniela ;

Hassel, Jessica C. ;

Meier, Friedegund ;

Tietze, Julia K. ;

Thomas, Ioannis ;

Weishaupt, Carsten ;

Leverkus, Martin ;

Wahl, Renate ;

Dietrich, Ursula ;

Garbe, Claus ;

Kirchberger, Michael C. ;

Eigentler, Thomas ;

Berking, Carola ;

Gesierich, Anja ;

Krackhardt, Angela M. ;

Schadendorf, Dirk ;

Schuler, Gerold ;

Dummer, Reinhard ;

Heinzerling, Lucie M. .

EUROPEAN JOURNAL OF CANCER, 2016, 60 :190-209

[9] Autoimmune pancreatitis: CT and MR characteristics [J].

Irie, H ;

Honda, H ;

Baba, S ;

Kuroiwa, T ;

Yoshimitsu, K ;

Tajima, T ;

Jimi, M ;

Sumii, T ;

Masuda, K .

AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 170 (05) :1323-1327

[10] Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition [J].

Melosky, Barbara ;

Chu, Quincy ;

Juergens, Rosalyn ;

Leighl, Natasha ;

McLeod, Deanna ;

Hirsh, Vera .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1676-U235

← 1 2 →